Acute Myeloid Leukaemia Therapeutics Market Current And Future Development 2023-2029
The Acute Myeloid Leukaemia (AML) Therapeutics Market, valued at USD 3.7 billion in 2022, is set to grow at a CAGR of 12.05%, reaching approximately USD 9.2 billion by 2029. This growth is attributed to advancements in medical technology and increased demand for effective AML treatments. Targeted therapies, immunotherapies, and personalized medicine...
0 Comments
0 Shares